发现辅助放化疗可以改善结肠癌预后。
Adjuvant radiation and chemotherapy found to improve survival in rectal cancer.
接受过辅助放化疗的胰腺癌患者有较长的存活时间。
Overall survival was better in patients who received adjuvant CT-RT.
目的探讨术前新辅助放化疗在可切除食管癌治疗中的作用。
Objective To explore the effect of pre-operative adjuvant chemo-radiotherapy and surgical treatment on resectable esophageal cancer.
最近，新辅助放化疗的出现已经根本改变了限局型浸润型结肠癌患者的治疗方式。
More recently, the emergence of neo-adjuvant chemoradiotherapy has fundamentally changed the management of patients with locally advanced disease.
本文对此药在非小细胞肺癌一线、二线、维持治疗和辅助放化疗方面最新的研究进展进行了回顾和展望。
The latest progresses of pemetrexed in first-line treatment, second-line treatment, maintenance treatment, and adjuvant chemotherapy of non-small cell lung cancer are reviewed in the article.
该研究对接受综合模式治疗的LRRC患者进行了评估，该模式包括新辅助放化疗、扩大切除术和术中放疗。
This study assessed the outcome of LRRC patients treated with multimodality treatment, consisting of neoadjuvant radio (chemo-) therapy, extended resection, and intraoperative radiotherapy.
目前的治疗方法很多，主要以手术切除为主，辅助放、化疗。
The present method of treatment are many, mainly excises by the surgery primarily, auxiliary assist, chemotherapy.
放、化疗作为骨外骨肉瘤的辅助治疗方法，在提高肿瘤的切除率和减少局部复发和远处转移等方面有帮助。
Radiotherpy and chemotherapy play an adjuvant role in the treatment of EOS, improve the resection rate and reduce the recurrence and metastasis.
目的：评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性，并探索标志物反应。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
结果扩大根治切除、新辅助放疗化疗、原位肝移植、光动力学治疗和分子放化疗均能有效地提高患者的生存率。
Results Extended radical resection, neoadjuvant chemotherapy, orthotopic liver transplantation, photodynamic therapy and molecular chemoradiotherapy might improve the survival rate.
结果扩大根治切除、新辅助放疗化疗、原位肝移植、光动力学治疗和分子放化疗均能有效地提高患者的生存率。
Results Extended radical resection, neoadjuvant chemotherapy, orthotopic liver transplantation, photodynamic therapy and molecular chemoradiotherapy might improve the survival rate.
应用推荐